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ABSTRACT  We have used two actin-binding proteins of the intestinal brush border, TW 260• 
240 and villin,  to examine the effects of filament cross-linking and filament length on myosin- 
actin interactions. TW 260/240 is a nonerythroid spectrin that is a potent cross-linker of actin 
filaments.  In  the  presence  of this cross-linker we observed  a concentration-dependent  en- 
hancement  of skeletal  muscle actomyosin  ATPase  activity  (150-560% of control;  maximum 
enhancement at a 1:70-80 TW 260[240:actin molar ratio). TW 260/240 did not cause a similar 
enhancement of either acto-heavy meromyosin (HMM) ATPase or acto-myosin subfragment- 
one ($1) ATPase. 
Villin, a Cae+-dependent filament capping and severing protein of the intestinal microvillus, 
was used to generate  populations of actin  filaments  of various  lengths from  <20  nm to  2.0 
/zm; (villin:actin  ratios of 1:2 to 1:4,000). The effect of filament  length on actomyosin ATPase 
was biphasic. At villin:actin  molar ratios of 1:2-25 actin-activated  myosin ATPase activity  was 
inhibited  to  20-80%  of  control  values,  with  maximum  inhibition  observed  at  the  highest 
villin:actin  ratio. The ATPase activities of acto-HMM and acto-S1 were also inhibited  at these 
short filament  lengths. At intermediate filament lengths generated at villin:actin  ratios of 1:40- 
400  (average  lengths  0.26-1.1  /~m) an  enhancement  of  actomyosin  ATPase  was  observed 
(130-260% of controls), with a maximum  enhancement at average filament lengths of 0.5/~m. 
The levels  of actomyosin ATPase fell off to control values at low concentrations of villin where 
filament  length  distributions  were almost those of controls.  Unlike  intact  myosin,  the actin- 
activated ATPase of neither HMM nor $1 showed an enhancement at these intermediate actin 
filament  lengths. 
In the cell,  myosin interacts with actin filaments of defined 
length which are often tethered to other structures such as the 
plasma membrane or other actin  filaments.  Many  specific 
actin-binding proteins have been identified which could func- 
tion  in  vivo to  regulate either actin  filament length  or the 
cross-linking state of filaments (for reviews see references 14 
and 32). Thus, to understand how actin-myosin interactions 
generate movement in  vivo, it is necessary to consider not 
only the isolated interaction of actin filaments with myosin 
but also the possible effect of these various classes of actin 
binding proteins on this interaction. 
In the present study, we have used two well-characterized 
actin-binding  proteins  to  examine the  effect of both  actin 
filament  cross-linking  and  actin  filament  length  on  the 
ATPase activity of myosin. For the cross-linking study, we 
used  TW  260/240,  a  tissue-specific  spectrin  of the  avian 
intestinal brush border (11),  which has been shown to be a 
potent cross-linker of actin filaments (9, 20).  This particular 
actin filament cross-linker was selected based on preliminary 
evidence  of Shimo-Oka  and  Watanabe  (23)  that  a  crude 
preparation of fodrin,  a  nonerythroid  spectrin  from mam- 
malian brain, stimulated actomyosin ATPase. These prelim- 
inary results were confirmed and extended by Wagner (29) 
while our own studies were in progress. To test the effect of 
filament  length  on  the  actin-myosin  interaction,  we  used 
various concentrations of the Ca2+-dependent actin capping 
and severing protein, villin,  to generate populations of actin 
filaments of various lengths (for reviews see references 6 and 
17). The results presented here have appeared in preliminary 
form elsewhere (4). 
MATERIALS  AND  METHODS 
Preparation of the Brush Borders:  Brush  borders  were isolated 
from the small intestines of chickens according to the method of Mooseker et 
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control proteolysis, we increased the  amount of aprolinin  (Sigma Chemical 
Co., St. Louis, MO) to 80-120 trypsin inhibitor  units (TIU)t/liter during the 
initial homogenization  steps and used 10-20 TIU/liter thereafter. 
Isolation of TW 260[240, Villin, Actin, Myosin, HMM, and 
S~:  TW 260/240  was purified by a modification of the methods of Glenney 
et al. ( 11 ) as described by Pearl et al. (20). Fractions of purified TW 260/240 
from the gel filtration column were concentrated  by dialysis against the brush 
border stabilization solution containing ammonium sulfate to 65% saturation. 
The precipitated protein was brought up in a minimal volume of 150 mM KCI, 
10 mM imidazole-Cl, pH 7.2, 1.0 mM MgCI2, 0.02% NAN3, 0.2 mM dithio- 
threitol  (DTT),  with 0.2 mM phenylmethylsulfonyl  fluoride (PMSF), and 20 
TIU/liter aprotinin. 
Villin was isolated by a modification of the method of Mooseker et al. (19). 
In brief, villin-containing  fractions from the above gel filtration column were 
pooled and dialyzed extensively against several changes of column buffer (20 
mM KCI, 0.2  mM CaCI2, 10 mM Tris-Cl, pH 8.2, 0,2  mM  DTT,  0.2  mM 
PMSF,  20 TIU/liter aprotinin).  Villin was purified on a  10-ml DEAE A-25 
column (Sigma Chemical  Co.) using a sharp linear  KCI gradient  (20 to 600 
mM; 25 ml per side ofchamber) in the above column buffer. After purification, 
villin was dialyzed against 75  mM KC1, 10 mM imidazole,  pH 7.2, 1.0 mM 
MgCI2, 0.02% NAN3, 0.2  mM  DTT with  0.2  mM  PMSF and  20 TIU/liter 
aprotinin and was used within 2 wk of purification. 
Chicken breast muscle actin was prepared from acetone powders following 
the method of Spudich and Watt (26). 
Chicken skeletal muscle myosin was prepared following the method of  either 
Margossian and Lowey (15) or Kielley and Harrington (13) with the substitution 
of 20  mM  imidazole-CI  (pH  7.0) for  potassium  phosphate  buffer  in  the 
extraction  solution. 
Both  HMM  and  Sj  were prepared  following the  methods  of Weeds and 
Taylor  (34) with  20  mM  imidazole-Cl substituted  for the suggested sodium 
phosphate.  HMM and S~ were separated from intact myosin and tail fragments 
following the methods of Weeds and Pope (33). Final purification and concen- 
tration  of both HMM and S~ was done by sizing on an agarose column (Biogel 
A  0.5, 200-400  mesh;  Bio-Rad  Laboratories,  Richmond,  CA)  followed by 
precipitation  with 65% saturated ammonium sulfate. 
Protein  concentrations  were  determined  using  the  following  values  for 
1%  .  A2so.m. myosin, 5.4 cm-~; HMM, 6.5 cm-~; S, 7.5 cm-~; G-actin,  10.9 cm-J; 
TW 260/240,  12.0 cm-~; villin, 13.0 cm-L Molar ratios of actin:TW 260/240 
were determined  assuming a dimer M~ of 500,000. 
ATPase Assay:  Two ATPase assays were used. The first was based on 
Pollard and Korn's (21) modification of Martin and Doty's (16) procedure and 
the  second was Taussky and Schorr's  (27) colorimetric  method.  Both assays 
were performed at 30"C in a final assay solution of 66 mM KCI, 5 mM MgCI2, 
0.2 mM CaCI2 or 0.5 mM EGTA, 8 or 20 mM imidazole, pH 7.2, and 2 mM 
ATP.  In some experiments  acto-HMM,  -S, and -myosin  ATPase activities 
were measured  at low ionic  strength--conditions identical  to the above  but 
containing  either  7 or  13  mM  KCI (for details, see Results). No significant 
change in pH occurred during the time course of these assays, as determined 
using  pH  papers.  The assays  using  the  method of Pollard  and  Korn  (21) 
contained  trace  amounts of  32P-3,-ATP. Protein  concentrations  used  were: 
actin, 6.0 gM (0.25 mg/ml); myosin, 0.26 uM (0.12 mg/ml); HMM, 0.26 uM 
(0.09  mg/ml); S~,  0.52 uM (0.06 mg/ml). For most experiments,  aetin  was 
polymerized  in the presence of either TW 260/240  or villin without ATP by 
incubating  for 30 rain at room temperature.  The samples were gently sheared 
by pipetting several times during the incubation  period.  In one set of experi- 
ments short populations  of actin  filaments were generated by the addition  of 
villin to preassembled  F-actin. The enzymes used for the assays were kept as 
concentrated  stocks  in  storage  buffer  (20  mM  imidazole,  1.0  mM  DTT) 
containing  either 0.6 M KCI (myosin), 75 mM KCI (SO or no added KCI (S, 
HMM).  To start the assay, enzyme then ATP (2.0 mM final) was added. Care 
was taken to maintain  the same order of addition  and comparable  mixing for 
all assays. Pilot experiments  established that phosphate release was approxi- 
mately linear under these conditions  and over the time course used. Specific 
activities reported here were determined  from 0- and 5-rain time points. 
Electron Microscopy:  The morphology of the proteins contained  in 
the various assays were visualized by either negative staining (with 2% aqueous 
uranyl acetate) or low-angle (-3  °) rotary shadowing (28) of negatively stained 
samples. This latter method produced  high-contrast images, facilitating length 
measurements.  For all results presented here except those in Fig. 7, aliquots of 
Abbreviations used in this paper." Co, critical  concentration; DTT, 
dithiothreitol;  HMM,  heavy meromyosin; PMSF,  phenyimethylsul- 
fonyl  fluoride;  S~,  myosin subfragment-one; TIU, trypsin inhibitor 
unit. 
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the ATPase assay mixtures were stored on ice and negatively stained within 2 
h after completion  of ATPase assays. Immediately  before staining,  the acto- 
myosin assay samples were diluted  1:5 in assay buffer without  ATP. In some 
experiments (see Fig. 7) the assay mixtures were stored on ice overnight before 
staining. No attempt  was made to determine  how much ATP remained in the 
assay mixtures at the time of staining. Lengths of villin-actin  filaments were 
measured  directly from enlarged micrographs  using an electronic planimeter 
(Numonics model  1224 Electronic Digitizer, Numonics Corp., Lansdale, PA). 
The shortest filaments we attempted  to measure were at a  1:8 molar ratio. At 
higher ratios  (1:2-1:5)  the villin-actin  filaments  were visualized as globular 
oligomeric complexes that generally had diameters <20 nm. 
RESULTS 
Effect of Actin Filament Cross-linking on 
Actomyosin,  -HMM, and -$1 A TPases 
We examined the concentration dependence of the effect 
of TW  260/240  on  actin-activated  myosin  Mg2+-ATPase. 
Under the conditions used we usually obtained a  7- to 30- 
fold increase in myosin ATPase in the presence of actin alone. 
In the presence of TW 260/240 we observed an enhancement 
of actomyosin ATPase at ratios as low as 1:300. This poten- 
tiation of activity reached a  maximum in the range of 1:80 
(Fig.  1). Although the extent of this enhancement varied with 
the  TW  260/240  preparation  (150%  to  560%),  the  peak 
activation was invariably at about the same ratio of TW 260/ 
240:actin (1:70 to 1:80). Higher ratios of TW 260/240:actin 
(>~ 1:40) were not routinely examined since the macroscopic 
aggregates of "gelled" actin filaments that are formed effec- 
tively remove actin  from solution (see  reference 20).  Acto- 
myosin ATPase assays at these higher concentrations of TW 
260/240  show  significant  but  highly  variable inhibition  of 
actin activation (data not shown).  Similar results have been 
reported by Dabrowska et al. (8) for the effect of high cross- 
linking concentrations offilamin on actomyosin ATPase, and 
on acto-HMM ATPase by Davies et at. (7). Control prepara- 
tions, including TW 260/240 alone, TW 260/240 plus actin, 
and TW 260/240 plus myosin, had little Mg2÷-ATPase activ- 
ity (results not shown). 
While  the  present  study  was  in  progress,  Wagner  (29) 
published a paper reporting on the effect of fodrin purified 
from bovine brain  on  actomyosin ATPase.  Similar to the 
results of the present study, results from that study showed 
that fodrin also has a "super-activating" effect on the actin- 
activated myosin ATPase. Furthermore, the addition of  fodrin 
caused the actomyosin ATPase to be Ca2÷-sensitive.  In the 
presence  of Ca  2÷,  fodrin  stimulated  actomyosin  ATPase, 
whereas in the presence ofEGTA fodrin inhibited actomyosin 
ATPase (29).  Unlike the situation with fodrin, we observed 
no significant Ca2÷-dependence on the enhancement of acto- 
myosin ATPase by TW 260/240  (Fig.  2). The range of en- 
hancement with or without Ca  2÷ in various preparations of 
actomyosin in the presence of TW 260/240 (at a  1:70 molar 
ratio) was 340-370% of control values (Fig. 2). 
The effect of TW 260/240 on acto-S~ and -HMM ATPases 
was also examined. Two different ionic strength assay condi- 
tions were examined, assay buffer containing 66 mM added 
KC1  (the  same conditions  used  for the  above actomyosin 
assays) and 13 mM KC1. The lower ionic strength assays were 
conducted (at the suggestion of one of the reviewers) because 
both  S~  and  HMM  exhibit  much  higher  actinoactivated 
ATPase activities under these conditions.  At this low ionic 
strength  the  actin-activated ATPase  of intact  myosin  still 
showed a significant enhancement above control levels in the 
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FIGURE  1  Concentration  dependence  of  TW  260• 
240 on actomyosin (O, ©), acto-S; (A, A), and acto- 
HMM  (0,  ~) ATPase.  Buffer  conditions were 5  mM 
MgCI2,  0.2  mM CaCI2 with either 20 mM  imidazole, 
pH  7.2 (O, O, A,  0,  0), or 8  mM  imidazole, pH  7.2 
(A), and either 66 mM KCI  (O,  A,  0) or  13  mM  KCl 
(O, A, ~). The control levels of ATPase in the absence 
of TW  260/240  were: myosin, 0.025  (O),  0.077  (O); 
actomyosin, 0.174 (O), 0.283 (O); S~, 0.106 (&), 0.083 
(A);  acto-S~,  0.303  (A),  1.647  (A);  HMM,  0.060  (0), 
0.057 (~); acto-HMM, 0.364 (0), 1.060 (0) where units 
are  micromolar  inorganic  phosphorus  (P~) per  milli- 
gram enzyme per minute. Graphs are plotted as per- 
cent activity of the actomyosin, acto-S1, or acto-HMM 
control  preparations.  The  molar  ratio  of  TW  260/ 
240:actin  is also expressed on the abscissa.  AM, ac- 
tomyosin. 
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FIGURE  2  Effect  of  Ca  2+  on  the  enhancement  of  actomyosin 
ATPase in the presence of TW 260/240. Assay  conditions were as 
in Fig. 1 with either 0.1  mM CaCI2 or 0.5 mM EGTA and a TW 260/ 
240:actin molar ratio of 1:70. AM, actomyosin. 
presence of TW 260/240 both at a  1:80 molar ratio and at a 
1:500 ratio, where at higher salt no enhancement is observed 
(Fig.  1). The effectiveness of TW 260/240 at very low concen- 
trations is presumably due  to the increased affinity of TW 
260/240  for actin  at low ionic strength  (20).  On the  other 
hand, no enhancement of either acto-S~ or HMM at either 66 
or 13 mM KC1 was observed (Fig.  1). 
Ultrastructural examination of ATPase assay mixtures re- 
vealed the dramatic cross-linking effect of TW 260/240  on 
actin  filaments.  In  control  actomyosin  preparations  actin 
filaments were uniformly distributed across the grid surface 
(Fig. 3 B), whereas actomyosin in the presence of a 1"70 molar 
ratio of TW 260/240:actin was present as sparsely distributed 
clumps of highly entangled actin filaments (Fig. 3A). At this 
low concentration of TW 260/240  obvious cross-links were 
not apparent. Furthermore, no myosin thick filaments were 
observed in any preparations in either the  presence or the 
absence of TW 260/240. 
Effect of Filament Length on Actomyosin, -HMM, 
and -$1 A TPases 
The effect of filament length on actomyosin ATPase was 
examined using various concentrations of  the Ca2÷-dependent 
capping and severing protein, villin, to generate populations 
of actin  filaments of varied lengths.  As shown by electron 
microscopy (5) and viscometry (19),  the length of actin fila- 
ments  achieved  at  steady  state  is,  in  a  qualitative  sense, 
inversely proportional to the concentration of villin present. 
Thus we were able to generate filament lengths from <20 nm 
(at  a  1:2  molar  ratio)  to  -2  pm  by  merely  varying  the 
concentration of villin (Figs.  4 and 5, and Table I). Control 
filament preparations in the absence of villin attained average 
lengths between 2 and 3 um. 
Myosin  ATPase  assays were  performed  using  "control" 
actin and villin-actin preparations. At villin:actin molar ratios 
between  1:2  and  1:25 (average lengths <20-200  nm) acto- 
myosin ATPase activity was inhibited by 20-80%, the extent 
of inhibition increasing with villin concentration (Fig. 6). One 
possible reason the lack of activation of myosin ATPase by 
short villin-actin filaments that could be examined directly 
was that short filaments formed by nucleated assembly in the 
presence of villin contain  primarily ATP-actin  monomers, 
since  it has recently been  shown  that  hydrolysis of bound 
ATP lags behind monomer addition (for review see reference 
35).  To test this possibility, we prepared short filaments by 
adding villin to preassembled F-actin. Such severed filaments 
should contain predominantly ADP monomers. We observed 
no difference in the inhibition of actomyosin ATPase by such 
short filaments generated by either severing or co-assembly 
with villin. For example, in one experiment at a 1:5 villin:actin 
ratio,  both  short  filament  populations  activated  myosin 
ATPase to only 35% of control actomyosin. 
At  intermediate  actin  filament  lengths  (average  lengths 
0.26-1.1 pm)generated at ratios of 1:40-1:400, enhancement 
of actomyosin ATPase was observed (130-260%  of controls; 
maximum activation at  1:70-400).  The extent of enhanced 
activation then fell off to control values at low concentrations 
of villin (1:2,000-4,000),  where filament length distributions 
were nearly at control levels (Fig.  5, Table I). Control prepa- 
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rations, including villin alone, villin plus actin, and villin plus 
myosin, had  little Mg2÷-ATPase activity (data not shown). 
On the other hand, the shearing of control actin preparations 
immediately before the  assay was  started  (by vigorous, re- 
peated pipetting), which produced shorter filaments (average 
length 0.98 ~m) than unsheared controls (average length 2.62 
~m),  also  enhanced  myosin  ATPase,  with  ATPase  levels 
-200% of control samples. 
Like myosin, both acto-HMM and acto-Sl ATPase activi- 
ties were inhibited at  high ratios of villin:actin (Fig.  6).  At 
intermediate actin  filament lengths,  however, neither acto- 
HMM nor acto-S~ showed the enhancement ofactin-activated 
ATPase  observed using  intact  myosin  (Fig.  6).  These two 
results--the inhibition with short filaments and the lack of 
enhancement with intermediate lengths--occurred at both 66 
and 7 mM KC1 (Fig. 6). 
As  in  the  TW  260/240  cross-linking experiment above, 
ultrastructural examination of  these preparations revealed the 
lack of any myosin thick filaments (Fig. 4). In several exper- 
iments, however, the assay mixtures were incubated overnight 
before negative staining. Under these conditions, myosin thick 
filaments were observed (Fig.  7), but only in those mixtures 
that  contained  very short  filaments generated at  high  vil- 
lin:actin ratios (1:2-10). 
DISCUSSION 
The Effect of TW 260/240 on 
Actin-Myosin Interaction 
The  results  presented  here  demonstrate  that  the  tissue- 
specific spectrin  of the  avian  brush  border,  TW  260/240, 
enhances the actin-activated Mg2+-ATPase activity of  skeletal 
muscle myosin. We attribute this effect to the cross-linking of 
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actin filaments by TW 260/240 rather than a direct interac- 
tion  of TW 260/240  and  myosin.  We  have, in  fact, been 
unable to  demonstrate any direct binding interactions be- 
tween TW 260/240 and myosin. For example, TW 260/240 
does not co-assemble with or inhibit the formation of myosin 
thick  filaments (data  not  shown).  Furthermore,  the  cross- 
linking  notion  is  supported  by the  observation that  other 
proteins that cross-link actin filaments--such as alpha-actinin 
(3,  24),  filamin (8,  25), and fodrin, a  nonerythroid spectrin 
purified  from  mammalian  brain  tissue  (22,  23,  29)--also 
enhance myosin ATPase activity over that observed in  the 
absence of an actin cross-linker.  See, for example, Fig. 6 of 
reference 8, which depicts the concentration dependence of 
filamin on actomyosin ATPase, demonstrating effects similar 
to those in Fig.  1 of this paper. In addition, like fodrin (29) 
and filamin (8), which do not enhance acto-Sl ATPase, the 
enhancement of myosin ATPase by TW 260/240 is observed 
only with intact myosin, not with either $1 or HMM. 
Assuming that it is the cross-linking of actin filaments by 
TW 260/240 that results in the enhancement of acto-myosin 
ATPase, there are a number of possible explanations for such 
an effect. The simplest is that cross-linking of actin filaments 
increased the local concentration ofactin binding sites acces- 
sible to a given myosin head. However, this mechanism fails 
to explain why no enhancement is observed when either St 
or HMM rather than myosin is used (Fig.  1). Another possi- 
bility  is  raised  by  the  fact  that  cross-linking  of filaments 
presumably will allow production of tension by myosin. Per- 
haps myosin works better under tension, but we are unaware 
of any evidence for this speculation. A problem with this idea 
is that myosin thick filaments, which might be necessary for 
force production, are not observed in the assay mixtures we 
have used in  these experiments (Fig.  3).  However, smaller 
MooseKer Actin Length and Cross-linking Regulate  Actomyosin  1853 FIGURE  4  Actomyosin ATPase assay mixtures in the presence of varied villin concentrations. The samples were first  negatively 
stained and  then  rotary shadowed to enhance contrast  (see Materials and  Methods).  Molar ratios of villin:actin are  indicated. 
Myosin thick tilaments were not observed in either the presence or the absence (C, control) of villin. Bar, 0.5 t~rn. x  51,600. 
bipolar arrays of myosin could provide tension  and be un- 
noticed due to the resolution of negative stain. 
Effect of Filament Length on 
Actin-Myosin Interaction 
The underlying assumption in  the studies presented here 
on the effect of filament length on actin-myosin interaction 
is that all of the villin-actin mixtures used are identical except 
for differences in filament length and number-concentration 
of filaments present.  Previous studies have shown that as a 
result of barbed-end capping (2,  10,  17) villin causes a  shift 
in the critical concentration (Co) of actin to that of  the pointed 
end (1). Under the conditions of this assay the Co is increased 
from -0.1 to ~0.6 ~M ( l, 30, 31). This shift in Co is saturated 
at very low villin:actin ratios (30, 31), such that except for the 
very low concentrations of villin  used  (1:4,000),  all  of the 
villin mixtures should have the same polymer concentration, 
which, in fact, is slightly lower than the total polymer concen- 
tration  of the  control  actin  in  the  absence of villin.  Since 
viUin-actin mixtures of 1:40-400 actually yield higher levels 
of actomyosin ATPase, this slight villin-dependent decrease 
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assays. One caution, however, is that the two studies (30,  31) 
that have examined the effect of villin on the Co used villin 
concentrations over a molar ratio range of 1:10-1,000.  Thus 
the  actual  Co  at  very  high  villin  ratios  has  not  yet  been 
determined directly and conceivably could be different from 
that measured in these initial studies. For example, if the Co 
for very short filaments were much greater than Co's previ- 
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FIGURE  5  Effect of villin on actin filament length. Average filament 
lengths  as  a  function  of  villin  concentration  for  the  two  villin 
preparations (11, e) used in the ATPase assays of Fig+ 5. The molar 
ratio of villin:actin is also indicated on the abscissa. Control filament 
preparations in the absence of villin attained average lengths  be- 
tween 2 and 3 ~m. 
ously observed, inhibition could simply be due to the presence 
of substantially less actin polymer. However, electron micros- 
copy of all villin-actin mixtures, even at very high villin:actin 
ratios, revealed ample amounts of polymer present (Fig.  4). 
Another caution is that villin may in some way alter the actual 
structure of F-actin (see below). 
Keeping in  mind the above reservations, it is possible to 
consider several mechanisms for the biphasic effect of fila- 
ment length on actin-myosin ATPase. The enhancement of 
actin-activated myosin ATPase by filaments of intermediate 
length (0.26 to 1.1 um) indicates that in vitro at least, there is 
an optimum length of filament for interaction with myosin. 
Since a  similar effect is not observed using either HMM or 
S,, it seems likely that the increased number-concentration of 
filaments present at intermediate  filament lengths as com- 
pared to control preparations is not the main causal factor in 
this enhancement. One possible explanation is that the intact 
myosin molecule is in an organizational state (albeit not in 
TABLE  I.  Average  Filament Lengths Produced at Various Villin:Actin 
Ratios 
Filaments  Average  Standard 
Sample  counted  length  deviation 
No.  #m  ~m 
No villin  228  2.14  1.79 
1:4,000  113  2.00  1.38 
1:2,000  262  1.89  1.57 
1:700  231  1.39  1.08 
1  : 150  234  0.50  0.44 
1:70  222  0.29  0.28 
1:30  335  0.16  0.15 
1:8  292  0.08  0.08 
I 
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FIGURE  6  Concentration  de- 
pendence of villin on actomyosin 
(•, O),  acto-S1  (A, A),  and  acto- 
HMM  (0) ATPase.  Buffer  condi- 
tion~ were as in Fig. 1 with either 
8  mM imidazole (11, 0, @) or 20 
mM  imidazole (A,  ~) and  either 
66 mM KCI (•, O, &) or 7 mM KCI 
(A,  ~).  The  control  levels  of 
ATPase  in  the  absence  of  villin 
were:  myosin,  0.030  (•),  0.026 
(0); actomyosin, 0.192 (•), 0.320 
(0); $I, 0.080 (A), 0.137 (A); acro- 
Ss,  0.450  (A),  1.560  (A);  HMM, 
0.084  (0);  acto-HMM,  1.618  (~) 
where units are micromolar inor- 
ganic  phosphorus  per  milligram 
enzyme  per  minute. Graphs are 
plotted as percent activity of the 
actomyosin,  acto-S1,  or  acto 
HMM  control  preparations.  The 
molar ratio  of  villin:actin  is  also 
expressed on the abscissa. 
O 4 
EVi Ilinl  O nM 
Molar  Ratio  1:~3OO  1:~0o  1:~5o 
lOO 
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conformation of monomers within these short filaments,  an 
effect that can be propagated only for a short distance down 
the  polymer  from  the  villin-capped  barbed  end.  Although 
deciphering the molecular basis for the ineffectiveness of short 
villin-actin  filaments to activate myosin ATPase will require 
further experiments,  it is clear that the results presented here 
in  these  initial  studies  establish  yet  another  way  in  which 
filament-severing  proteins  such  as  villin  might  regulate  not 
only cytoplasmic structure but also contractility in the cell. 
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FIGURE  7  Ultrastructural  examination  of  villin-actomyosin  assay 
mixtures after incubation overnight before negative staining. Myosin 
thick  filaments  were observed  but  only  in  the  presence  of  high 
villin concentrations (e.g., at  1:2 villin:actin molar ratio used here). 
The  background shows a  uniform  distribution of tiny  actin oligo- 
mers. Bar, 200 nm. x  63,500. 
large, thick filaments) and that, due to its size or organization, 
it can  interact  most efficiently  with actin  filaments  of inter- 
mediate length, perhaps as a result of more efficient  packing 
of these  shorter-than-control  filaments  around the  heads of 
the  myosin  molecule.  That  the  potentiation  of actomyosin 
ATPase  by  filaments  of intermediate  lengths  is  strictly  an 
effect of length and not some effect ofvillin on those filaments 
is strongly supported by the observation that similar enhance- 
ment is seen with control actin  filaments  vigorously sheared 
immediately before use in the ATPase assay. 
The  inhibition  of the  activities  of both  actomyosin  and 
acto-S~  by very short filaments generated at high villin:actin 
ratios (1:2  to  1:25)  suggests that there  might be  some  mini- 
mum  filament  length  necessary  for  efficient  myosin-actin 
interaction. Perhaps myosin molecules "travel" down a single 
filament for multiple cycles of ATP hydrolysis, just as myosin 
might do in muscle contraction. In this case, interactions with 
a  short  filament  would  be  less  efficient,  since  the  myosin 
would fall off a given filament more frequently. Alternatively, 
short villin:actin filaments might be structurally different from 
control  filaments,  resulting  in  a  lower  affinity  for  myosin. 
Villin bound to the barbed end of very short filaments might 
directly hinder myosin-actin  binding through steric interfer- 
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